Gratus Capital, LLC

Holdings History for Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024	0.58%	+0.01%	$14,495,689	418,346	+10,173	+2.5%	$34.65	Q2 2024
31 Mar 2024	0.54%	+0.01%	$11,808,445	408,173	+10,602	+2.7%	$28.93	Q1 2024
31 Dec 2023	0.52%	+0.14%	$9,116,304	397,571	+104,702	+36%	$22.93	Q4 2023
30 Sep 2023	0.33%	+0.08%	$4,885,055	292,869	+73,283	+33%	$16.68	Q3 2023
30 Jun 2023	0.42%	+0.01%	$6,064,966	219,586	+7,855	+3.7%	$27.62	Q2 2023
31 Mar 2023	0.37%	-0.01%	$4,869,813	211,731	-7,328	-3.3%	$23.00	Q1 2023
31 Dec 2022	0.2%	+0.01%	$2,389,934	219,059	+12,946	+6.3%	$10.91	Q4 2022
30 Sep 2022	0.19%	+0.19%	$1,738,000	206,113	+206,113	NEW	$8.43	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.